İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

TUĞBA SONGÜL TAT

PROFESÖR

HASAN KALYONCU ÜNİVERSİTESİ MESLEK YÜKSEKOKULU TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal İmmünoloji ve Alerjii Hastalıkları

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 15
  • Proje 0
  • Kitap 2
  • Bildiri 4
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 1 Q2 9 Q3 1 Q4 0
WoS (JCR) Q1 0 Q2 4 Q3 8 Q4 4
TR Index 6 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 4
Ort. yüzdelik 70.0%
Üst %1 payı 0.0%
Üst %10 payı 26.7%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 15 yayın

Scopus (SJR)
WoS (JCR)
TR Index

Makale listesi

  1. 2025 Decreased 25-hydroxyvitamin D levels in chronic spontaneous urticaria and its relationship with disease activity Medicine DOI 10.1097/MD.0000000000042640 YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.2%
  2. 2023 False negative effect of high triglycerides concentration on vitamin D levels: A big data study Journal of Medical Biochemistry DOI 10.5937/jomb0-40106 YÖKSİS SJR Q2 JCR Q4 OpenAlex 60.2%
  3. 2022 Omalizumab is effective in nasal polyposis with or without asthma, a real-life study World Allergy Organization Journal DOI 10.1016/j.waojou.2022.100670 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.5%
  4. 2022 Rare Side Effects after Inactiveted Sars-Cov-2 Vaccine (Coronavac) Konuralp Tip Dergisi DOI 10.18521/ktd.1061482 YÖKSİS TR Index JCR Q3 OpenAlex 37.8%
  5. 2019 Higher Levels of Depression and Anxiety in Patients with Chronic Urticaria Medical Science Monitor DOI 10.12659/MSM.912362 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 96.4%
  6. 2019 Kronik ürtikerli hastalarda troid otoimmünitesi ve artmış nötrofil lenfosit oranı TURKISH JOURNAL of CLINICS and LABORATORY DOI 10.18663/tjcl.521024 YÖKSİS TR Index OpenAlex 48.8%
  7. 2018 Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study Medical Science Monitor DOI 10.12659/MSM.910860 YÖKSİS SJR Q2 JCR Q3 OpenAlex 70.4%
  8. 2018 Kronik spontan ürtikerde omalizumab tedavisinin etkinliği ve güvenliği Cukurova Medical Journal DOI 10.17826/cumj.364820 YÖKSİS TR Index JCR Q3 OpenAlex 52.6%
  9. 2017 Omalizumab Treatment in Patients with Severe Allergic Asthma Istanbul Medical Journal DOI 10.5152/imj.2017.93653 YÖKSİS TR Index JCR Q4 OpenAlex 52.4%
  10. 2016 Omalizumab treatment in asthma COPD overlap syndrome Journal of Asthma DOI 10.1080/02770903.2016.1178281 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.6%
  11. 2016 Evaluation of long term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma Annals of Allergy, Asthma & Immunology DOI 10.1016/j.anai.2016.09.006 YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.8%
  12. 2009 Can a high platelet count be responsible for diabetes insipidus in acute myelogenous leukemia with monosomy 7 and inversion 3 (q21q26)? International Journal of Hematology DOI 10.1007/s12185-009-0396-0 YÖKSİS SJR Q2 JCR Q4 OpenAlex 60.5%
  13. 2022 Rare Side Effects After Inactiveted Sars-Cov-2 Vaccine (Coronavac) Konuralp Tıp Dergisi DOI 10.18521/ktd.1061482 YÖKSİS TR Index JCR Q3 OpenAlex 37.8%
  14. 2018 Erişkin İdiyopatik Trombositopenik Purpuralu Hastalarda IL-10 ve IL-17 gen polimorfizmi Namık Kemal Tıp Dergisi DOI http://dergipark.gov.tr/download/article-file/534532 YÖKSİS TR Index JCR Q4
  15. 2016 Omalizumab treatment in asthma-COPD overlap syndrome JOURNAL OF ASTHMA DOI 10.1080/02770903.2016.1178281 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.6%
  16. 2016 Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma Annals of Allergy, Asthma Immunology DOI 10.1016/j.anai.2016.09.006 YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.8%
  17. 2015 Trabzon’da Kanser Tarama Testleri Farkındalığı Journal of Human Rhythm YÖKSİS
  18. 2012 Evaluation of nutritional parameters of hemodialysis patients Hippokratia DOI https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738730/ YÖKSİS SJR Q3 JCR Q3

Akademisyenlere dön